Bio-Nexus Overview

  • Year Founded
  • 2010

Year Founded

  • Status
  • Out of Business

  • Employees
  • 25

Employees

  • Latest Deal Type
  • Liquidation

Bio-Nexus General Information

Description

Developer of a cloud-based platform created to facilitate rapid workflow processing, The company's platform obtains data from information systems companies, which then processes it and digitizes any process or workflow to create step-by-step interactive protocols and digital records, thus enabling businesses in the medical, aviation, military and industrial sectors with end-to-end digital maintenance that addresses the challenges of high-cost, high-risk workflow processes.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • 4th Arie Regev Street
  • Poleg Industrial Zone, P.O. Box 8510
  • Netanya 42504
  • Israel
+972
Primary Industry
Business/Productivity Software
Other Industries
Media and Information Services (B2B)
Automation/Workflow Software
Vertical(s)
Corporate Office
  • 4th Arie Regev Street
  • Poleg Industrial Zone, P.O. Box 8510
  • Netanya 42504
  • Israel
+972

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Bio-Nexus Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Bankruptcy: Liquidation 01-Dec-2019 Completed Bankruptcy: Liquidation
1. Later Stage VC (Series A) 16-Aug-2016 Completed Generating Revenue
To view Bio-Nexus’s complete valuation and funding history, request access »

Bio-Nexus Patents

Bio-Nexus Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20120166203-A1 System and method for mobile workflow processing Inactive 20-Dec-2010
WO-2012087900-A2 System and method for mobile workflow processing Inactive 20-Dec-2010
WO-2012087900-A3 System and method for mobile workflow processing Inactive 20-Dec-2010
US-9180155-B2 Compositions from nigella sativa Inactive 29-Nov-2010
US-20100028468-A1 Formulations containing thymoquinone for urinary health Active 29-Jul-2008 A61K31/195
To view Bio-Nexus’s complete patent history, request access »

Bio-Nexus Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Bio-Nexus Acquisitions (1)

Bio-Nexus’s most recent deal was a Merger/Acquisition with Cleerio. The deal was made on 14-Aug-2017.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Cleerio 14-Aug-2017 Merger/Acquisition Business/Productivity Software
To view Bio-Nexus’s complete acquisitions history, request access »

Bio-Nexus FAQs

  • When was Bio-Nexus founded?

    Bio-Nexus was founded in 2010.

  • Where is Bio-Nexus headquartered?

    Bio-Nexus is headquartered in Netanya, Israel.

  • What is the size of Bio-Nexus?

    Bio-Nexus has 25 total employees.

  • What industry is Bio-Nexus in?

    Bio-Nexus’s primary industry is Business/Productivity Software.

  • Is Bio-Nexus a private or public company?

    Bio-Nexus is a Private company.

  • What is Bio-Nexus’s current revenue?

    The current revenue for Bio-Nexus is .

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process